anaplastic astrocytoma
astrocytoma anaplasticum latin

One complete response was achieved in a patient with anaplastic astrocytoma.

Temozolomide is approved for the treatment of patients with anaplastic astrocytoma.

An anaplastic astrocytoma may progress to a higher grade and become a glioblastoma.

The two other categories in the newer system are called anaplastic astrocytoma and glioblastoma.

Those with anaplastic astrocytoma survive about three years.

On the other hand, high-grade astrocytomas such as Anaplastic astrocytoma have worse prognoses.

An anaplastic astrocytoma forms most often in the cerebrum and is most common in adults.

The patient with anaplastic astrocytoma received antineoplaston AS2-1 in addition to other chemotherapy and radiation.

Less than 10% form more slowly following degeneration of low-grade astrocytoma or anaplastic astrocytoma.

Anaplastic astrocytoma is a WHO grade 3 type of astrocytoma.

Anaplastic astrocytoma.

Anaplastic astrocytoma is classified as grade III and are malignant tumors.

Malignant tumors like anaplastic astrocytoma and glioblastoma multiforme, however, require more aggressive therapy.

Anaplastic astrocytoma occurs most often in adults between the ages of 30 and 50, and accounts for 4% of all brain tumors.

It is difficult to distinguish from highly infiltrative anaplastic astrocytoma or GBM.

In many cases, patients with anaplastic astrocytoma may experience various types of paralysis, speech impediments, difficulties planning and skewed sensory perception.

Temozolomide is a chemotheraputic drug used in the treatment of Glioblastoma multiforme and Anaplastic astrocytoma.

Sometimes a diffuse astrocytoma progresses to a higher grade and becomes an anaplastic astrocytoma or a glioblastoma.

An anaplastic astrocytoma is also called a malignant astrocytoma or high-grade astrocytoma.

Recurrent brain tumor (anaplastic astrocytoma or glioblastoma multiforme)

Although temozolomide is effective for treating recurrent anaplastic astrocytoma, its role as an adjuvant to radiation therapy has not been fully tested.

It appears that a year or so before Pascal left Sundog she was diagnosed with some form of incurable brain cancer, anaplastic astrocytoma.'

This type of tumor typically affects young adults and has a tendency for malignant progression to anaplastic astrocytoma and, ultimately, glioblastoma.

(Refer to the Anaplastic Astrocytoma section in the Classification section of this summary for more information.)

Secondary glioblastoma is the term used to describe a glioblastoma developed from a diffuse astrocytoma or an anaplastic astrocytoma.